期刊文献+

胃泌素受体拮抗剂抑制胰腺癌细胞生长的初步研究 被引量:1

Proliferation Inhibition Effect of Gastrin Receptor Antagonist on Pancreatic Adenocacinoma Cells
下载PDF
导出
摘要 目的探讨应用胃泌素受体拮抗剂治疗胰腺癌的可行性。方法在体外条件下观察胃泌素及其受体拮抗剂丙谷胺对胰腺癌细胞株的细胞活力及细胞增殖的影响。结果在体外条件下,胃泌素能促进胰腺癌细胞株的增殖,而丙谷胺能完全阻断胃泌素的作用。结论胃泌素受体拮抗剂能够抑制胃泌素受体阳性的胰腺癌细胞生长,有望为胰腺癌的治疗提供一种新手段。 Objective To explore the feasibility of gastrin receptor antagonist application in the management of pancreatic adenocacinoma.Methods The viability and proliferation of pancreatic adenocacinoma cell line treated with gastrin and its receptor antagonist proglumide were observed in vitro.Results The proliferation of pancreatic adenocacinoma cell line cells were promoted by the gastrin,while were totally blocked by proglumide.Conclusion Gastrin receptor antagonist could inhibit the growth of gastrin-receptor positive pancreatic adenocacinoma cells,indicating a new possible therapeutic method.
作者 叶静
出处 《医学研究杂志》 2011年第2期81-82,89,共3页 Journal of Medical Research
关键词 胃泌素 受体拮抗剂 胰腺癌 丙谷胺 Gastrin Receptor antagonist Pancreatic adenocacinoma Proglumide
  • 相关文献

参考文献5

二级参考文献12

共引文献11

同被引文献25

  • 1杨红,钱家鸣,郭涛.胰腺癌300例诊断分析[J].临床误诊误治,2006,19(4):32-33. 被引量:8
  • 2张成康,汪垣.人核受体hblf(nr5a2)的基因结构及其转录调控[D].北京:中国科学院研究生院,2002.
  • 3Zhang ZL, Bai ZH, Wang XB, et al. miR-186 and 326 predict the prognosis of pancreatic ductaladenocarcinoma and affect the prolifera- tion and migration of cancer cells [ J ]. PLoS One, 2015,10 ( 3 ) : 118814.
  • 4Long J, Luo GP, Xiao ZW, et al. Cancer statistics : current diagnosis and treatment of pancreatic cancer in Shanghai, China [ J ]. Cancer Lett,2014,346 ( 2 ) :273-277.
  • 5Fayard E, Auwerx J, SchoonjansK. LRH-1 : an orphan nuclear recep- tor involved in development, metabolism and steroidngenesis [ J]. Trends Cell Bio1,2004,14 ( 5 ) :250-260.
  • 6Sheela SG, Lee WC, Lin WW ,et al. Zebrafish ftz-fla( nuclear recep- tor 5A2 )functions in skeletal muscle organization [ J]. Dev Biol, 2005,286(2) :377-390.
  • 7Robert NM, Miyamoto Y, Taniguchi H, et al. LRH-1/NR5A2 cooper- ates with GATA factors to regulate inhibin alpha-subunit promoter ac- tivity [ J ]. Mol Cell Endocrinol, 2006 ( 257-258 ) :65 -74.
  • 8Wittekind C, Oberschmid B. TNM classification of malignant tumors 2010:General aspects and amendments in the general section[ J]. Pathologe ,2010,31 (5) :333-334,336-338.
  • 9Edge SB, Compton CC. The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM [ J ]. Ann Surg Oncol,2010,17 (6) : 1471 - 1474.
  • 10vagne-r'RT, Xu X, Yi F, et al. Canonical Wnt/beta-catenin regula- tion of liver receptor homolog-1 mediates pluripotency gene expres- sion [ J ]. Stem Cells,2010,28 (10) : 1794-1804.

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部